You are developing a new drug to treat Major Depressive Disorder(MDD). You know that patients do not show clinical signs ofimprovement when they begin taking an SSRI. Your goal is to createa drug that will result in immediate improvement for patients, andcan be used with SSRIs initially, and discontinued once the SSRIbecomes fully effective. a. Explain how SSRIs affect transmissionat serotonin synapses, and why clinical effects are not seenimmediately after a patient starts taking this medication. b. Whatpart of neuronal transmission would you target with your drug? Whywould this alleviate the issue with SSRIs?
